GlassScriptPhysician profile
Sara Lynn Schrader
NPI 1558337592
$17,911.74
in general payments reported to CMS, 2019-2025
61 companies · $3,463 in 2025
The $3,463 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,561 · 2020: $1,621 · 2021: $1,822 · 2022: $3,108 · 2023: $3,034 · 2024: $3,302 · 2025: $3,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,799.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,602.50 | 2020-2025 | Qulipta, Botox, Ubrelvy |
| Mdd US Operations, LLC | $1,459.72 | 2019-2025 | Apokyn, Apokyn |
| Biogen, INC. | $1,205.63 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Ucb, INC. | $1,098.55 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Novartis Pharmaceuticals Corporation | $1,095.57 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $847.05 | 2019-2022 | |
| Catalyst Pharmaceuticals, INC. | $801.86 | 2022-2025 | Fycompa |
| Eisai INC. | $701.63 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $682.15 | 2019-2025 | |
| Sk Life Science, INC. | $663.82 | 2020-2025 | |
| Emd Serono, INC. | $643.61 | 2019-2025 | Mavenclad |
| Amgen INC. | $544.66 | 2019-2025 | Uplizna, Aimovig |
| Neurocrine Biosciences, INC. | $520.92 | 2019-2025 | Ingrezza |
| Alexion Pharmaceuticals, INC. | $406.01 | 2019-2025 | Ultomiris, Soliris |
| Lilly USA, LLC | $388.09 | 2019-2025 | Emgality, Kisunla, Reyvow |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $387.47 | 2019-2025 | Vyepti |
| Genzyme Corporation | $334.61 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $293.51 | 2019-2025 | Rytary, Crexont |
| Harmony Biosciences LLC | $293.19 | 2022-2025 | Wakix |
| Vanda Pharmaceuticals INC. | $250.54 | 2021-2025 | Hetlioz, Fanapt, Ponvory |
| Allergan, INC. | $236.51 | 2019-2022 | |
| Argenx US, INC. | $233.61 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Genentech USA, INC. | $218.52 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Biohaven Pharmaceutical Holding Company LTD. | $217.68 | 2022 | |
| Sumitomo Pharma America, INC. | $191.63 | 2023-2024 | Aptiom, Brovana |
| Sunovion Pharmaceuticals INC. | $171.18 | 2019-2022 | |
| Kyowa Kirin, INC. | $160.23 | 2019-2024 | Nourianz |
| Acadia Pharmaceuticals INC | $155.51 | 2020-2025 | Nuplazid, Daybue |
| Livanova USA, INC. | $145.24 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Janssen Pharmaceuticals, INC | $144.42 | 2022-2024 | Spravato |
| Pfizer INC. | $136.65 | 2019-2025 | |
| Neurelis, INC. | $131.08 | 2020-2024 | Valtoco |
| Horizon Therapeutics Plc | $119.15 | 2022-2023 | Uplizna |
| Medtronic, INC. | $118.17 | 2023 | Solitaire X |
| Takeda Pharmaceuticals U.S.A., INC. | $116.83 | 2023-2025 | Hyqvia, Gammagard |
| Teva Pharmaceuticals USA, INC. | $109.82 | 2020-2024 | Austedo Xr, Ajovy |
| Banner Life Sciences, LLC | $100.06 | 2021-2024 | |
| Aprecia Pharmaceuticals, LLC | $83.15 | 2020-2023 | Spritam |
| Greenwich Biosciences, INC. | $80.11 | 2019-2021 | |
| Celgene Corporation | $75.03 | 2021-2025 | Zeposia |
| Biohaven Pharmaceuticals, INC. | $74.35 | 2021 | |
| Mallinckrodt Hospital Products INC. | $67.72 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $64.31 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $62.47 | 2020-2022 | |
| Upsher-Smith Laboratories LLC | $58.04 | 2021-2023 | |
| Octapharma USA, INC. | $49.26 | 2023 | Panzyga |
| Tg Therapeutics, INC. | $45.12 | 2024 | |
| Mallinckrodt Enterprises LLC | $42.70 | 2019 | |
| Acorda Therapeutics, INC | $40.46 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $28.36 | 2023 | Trudhesa |
| Ani Pharmaceuticals, INC. | $27.55 | 2023 | Purified Cortrophin Gel |
| Avadel Cns Pharmaceuticals, LLC | $26.49 | 2024 | Lumryz |
| Springworks Therapeutics, INC. | $21.47 | 2025 | Gomekli |
| Arbor Pharmaceuticals, INC. | $20.40 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $19.57 | 2023 | Nuedexta |
| Csl Behring | $19.21 | 2025 | Hizentra |
| Adamas Pharmaceuticals, INC. | $18.73 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.76 | 2022 | |
| Avion Pharmaceuticals | $15.32 | 2023 | Dhivy |
| Chiesi USA, INC. | $14.42 | 2024 | Cleviprex |
| Aucta Pharmaceuticals, INC. | $14.36 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Schrader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.